Real-world safety of pemetrexed, carboplatin, and pembrolizumab in U.S. NSCLC patients.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.5_suppl.50
Abstract: 50Background: A Phase 3 KEYNOTE-189 clinical trial showed improved clinical benefit with acceptable toxicity of pemetrexed combined with pembrolizumab and platinum (Gandhi, 2018). However, the safe... read more here.
Keywords: real world; carboplatin pembrolizumab; safety pemetrexed; pemetrexed carboplatin ... See more keywords